logo
Select company
Select metric
30.81%Operating Cash Flow Margin
VS
Market
83
Sector
95
Industry
95
History
92
$ 33.53Close
$ 5.9 - $ 35.6 52-Week Range
Ticker Information

Ticker

STOK

Company Name

STOKE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

STOKE THERAPEUTICS INC - Operating Cash Flow Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

STOK - OCF % Historical data
DateNet Cash Flow - OperationsOperating Cash Flow MarginRevenues
6/30/2025$ 61.6M30.81%$ 199.89M
3/31/2025$ 69.54M36.43%$ 190.91M
12/31/2024$ -86.85M-237.59%$ 36.55M
9/30/2024$ -84.31M-503.54%$ 16.74M
6/30/2024$ -79.95M-527.51%$ 15.16M
3/31/2024$ -84.28M-1074.28%$ 7.84M
12/31/2023$ -81.07M-923.31%$ 8.78M
9/30/2023$ -82.79M-895.33%$ 9.25M
6/30/2023$ -87.58M-990.33%$ 8.84M
3/31/2023$ -85.71M-588.85%$ 14.56M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • STOKE THERAPEUTICS INC's latest trailing twelve months (TTM) OCF % stands at 0%.
  • Over the past 5 years, STOKE THERAPEUTICS INC's average OCF % has been -498.8%.
  • The median OCF % for STOKE THERAPEUTICS INC during this period was -489.77%
  • STOKE THERAPEUTICS INC reached its highest OCF % over the past 5 years at 36.43%.
  • The lowest OCF % recorded by STOKE THERAPEUTICS INC in the same timeframe -1074.28%

STOKE THERAPEUTICS INC's OCF % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

OCF % Benchmarks
CompanyOCF %
AKBA : AKEBIA THERAPEUTICS INC -1.18%DAWN : DAY ONE BIOPHARMACEUTICALS INC -33.61%DNA : GINKGO BIOWORKS HOLDINGS INC -102.99%MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -9.8%GERN : GERON CORP -108.41%KROS : KEROS THERAPEUTICS INC 23.64%NAGE : NIAGEN BIOSCIENCE INC 18.24%CRMD : CORMEDIX INC 25.08%IOVA : IOVANCE BIOTHERAPEUTICS INC -125.62%PHAT : PHATHOM PHARMACEUTICALS INC -240.87%

Definition of Operating Cash Flow Margin

[Calculation] The company's operating cash flow [NCFO] expressed as a percentage of [Revenue].
CF - Operations / Revenues
(=) OCF %
OCF % for STOKE THERAPEUTICS INC is calculated as follows: CF - Operations [ $ -41.49M ] / Revenues [ $ 0 ]
(=) OCF % [ 0% ]

STOK - Operating Cash Flow Margin, Last 5 years

-1074.28%

Minimum

Mar 31, 2024

36.43%

Maximum

Mar 31, 2025

-498.8%

Average

-489.77%

Median

OCF % Benchmark Analysis

The chart above depicts the distribution of OCF % for companies in the Total Stock Market. The average OCF % of the companies is 14.31% with a standard deviation of 21.13%.
The following table provides additional summary stats:
OCF % in the Market:
filtered constituents3.25K
min-57.27%
max77.08%
average14.31%
median12.65%
std21.13%